企業プロフィール
Bellerophon Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- BLPH
- 取引所:
- PINK
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for BLPH.
企業概要
事業概要
Bellerophon Therapeutics was a pulmonary-hypertension company focused on inhaled nitric-oxide and cardiopulmonary science before its restructuring and public-market decline. Its platform targeted severe lung disease.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ before restructuring, Bellerophon sat in specialty biotechnology.
ビジネスモデルの特徴
The business depended on clinical validation, delivery science, and the ability to commercialize a focused respiratory platform.
バイオ業界での位置付け
Bellerophon belongs to the historical respiratory-biotech set rather than the current live public-company set.
今後のカタリスト
- Bellerophon Therapeutics’s catalysts are INOpulse-related updates and any strategic move that clarifies the company’s future. The market is mostly waiting to see whether there is still a viable commercial or asset path.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。